We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
The RMR Group
RMR
$304M
| $1.18M | ﹤0.01% |
30,610
-1,378
| -4% | -$45.3K |
2017 Q3
13 quarters
|
|
1502
Pilgrim's Pride
PPC
$6.69B
| $1.18M | ﹤0.01% |
60,128
-215
| -0.4% | -$3.89K |
2015 Q1
23 quarters
|
|
1503
Valley National Bancorp
VLY
$7.63B
| $1.18M | ﹤0.01% |
120,708
-100
| -0.1% | -$870 |
2015 Q2
22 quarters
|
|
1504
Editas Medicine
EDIT
$382M
| $1.18M | ﹤0.01% |
16,774
+678
| +4% | +$27.9K |
2019 Q4
4 quarters
|
|
1505
FirstCash
FCFS
$8.01B
| $1.18M | ﹤0.01% |
16,788
-76
| -0.5% | -$4.82K |
2016 Q1
19 quarters
|
|
1506
Builders FirstSource
BLDR
$6.19B
| $1.17M | ﹤0.01% |
28,745
+7,006
| +32% | +$248K |
2016 Q4
16 quarters
|
|
1507
Eagle Materials
EXP
$5.48B
| $1.17M | ﹤0.01% |
11,577
+596
| +5% | +$55.4K |
2014 Q1
27 quarters
|
|
1508
JetBlue
JBLU
$1000M
| $1.17M | ﹤0.01% |
80,548
+4,480
| +6% | +$61.5K |
2013 Q4
28 quarters
|
|
1509
Interface
TILE
$2.11B
| $1.17M | ﹤0.01% |
111,411
-15,015
| -12% | -$120K |
2014 Q3
25 quarters
|
|
1510
DELISTED
Smartsheet Inc.
SMAR
| $1.17M | ﹤0.01% |
16,873
+4,246
| +34% | +$249K |
2020 Q1
3 quarters
|
|
|
ARNA
1511
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.17M | ﹤0.01% |
15,210
+1,888
| +14% | +$142K |
2018 Q4
8 quarters
|
|
1512
Capitol Federal Financial
CFFN
$1.03B
| $1.16M | ﹤0.01% |
93,252
+7,733
| +9% | +$92.3K |
2014 Q1
27 quarters
|
|
1513
DELISTED
Vonage Holdings Corporation
VG
| $1.16M | ﹤0.01% |
90,464
+3,092
| +4% | +$37.6K |
2013 Q4
28 quarters
|
|
1514
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.16M | ﹤0.01% |
39,294
+2,513
| +7% | +$75.5K |
2014 Q3
25 quarters
|
|
1515
Alarm.com
ALRM
$3.07B
| $1.16M | ﹤0.01% |
11,225
+4,012
| +56% | +$291K |
2020 Q1
3 quarters
|
|
1516
Columbia Sportswear
COLM
$3.18B
| $1.16M | ﹤0.01% |
13,282
-163
| -1% | -$14.2K |
2014 Q2
26 quarters
|
|
1517
Horizon Bancorp
HBNC
$1.03B
| $1.16M | ﹤0.01% |
73,217
-508
| -0.7% | -$6.96K |
2018 Q4
8 quarters
|
|
1518
The Greenbrier Companies
GBX
$1.2B
| $1.16M | ﹤0.01% |
31,825
+76
| +0.2% | +$2.51K |
2014 Q1
27 quarters
|
|
1519
Futu Holdings
FUTU
$13.9B
| $1.16M | ﹤0.01% |
25,295
+616
| +2% | +$23.2K |
2020 Q1
3 quarters
|
|
1520
Lakefront Biotherapeutics American Depositary Shares
LKFT
$2.06B
| $1.16M | ﹤0.01% |
11,694
-578
| -5% | -$70.7K |
2017 Q1
15 quarters
|
|
1521
Intellia Therapeutics
NTLA
$1.56B
| $1.15M | ﹤0.01% |
21,163
+1,539
| +8% | +$55.9K |
2019 Q4
4 quarters
|
|
|
MDRX
1522
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.15M | ﹤0.01% |
79,631
-1,746
| -2% | -$21.1K |
2016 Q4
16 quarters
|
|
1523
Diversified Healthcare Trust
DHC
$1.91B
| $1.15M | ﹤0.01% |
278,613
-39,961
| -13% | -$157K |
2014 Q1
27 quarters
|
|
1524
Merit Medical Systems
MMSI
$5.61B
| $1.15M | ﹤0.01% |
20,639
+118
| +0.6% | +$6.09K |
2016 Q3
17 quarters
|
|
1525
Elme Communities
ELME
$157M
| $1.14M | ﹤0.01% |
52,831
-11,881
| -18% | -$254K |
2016 Q1
19 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.